The FDA has authorized an expanded access program that will allow for the use of a recombinant bacillus Calmette-Guerin product.
Agadia, a leader in Utilization Management automation, is proud to announce the expansion of its electronic prior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback